• 26-Sep-2023 Investor Presentation Correction Investor Presentation Correction
• 26-Sep-2023 Investor Presentation Correction Investor Presentation Correction
• 26-Sep-2023 Cyclopharm Investor Update Cyclopharm Investor Update
• 12-Sep-2023 Application for quotation of securities - CYC Application for quotation of securities - CYC
• 25-Aug-2023 Litigation Update and Receipt of Settlement Payment Litigation Update and Receipt of Settlement Payment
• 22-Aug-2023 Dividend/Distribution - CYC Dividend/Distribution - CYC
• 22-Aug-2023 Half Year Accounts Half Year Accounts
• 9-Aug-2023 USFDA Approval Process Update USFDA Approval Process Update
• 17-Jul-2023 Cyclopharm 2023 Half Year Accounts Update - Record Revenues Cyclopharm 2023 Half Year Accounts Update - Record Revenues
• 16-May-2023 Notification of buy-back - CYC Notification of buy-back - CYC
• 16-May-2023 Results of Meeting Results of Meeting
• 16-May-2023 Managing Director's Address to Shareholders Managing Director's Address to Shareholders

Click here for archives